We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · August 15, 2020

Clinical Characteristics and Outcomes of Extranodal Stage I DLBCL in the Rituximab Era



Additional Info

Clinical Characteristics and Outcomes of Extranodal Stage I Diffuse Large B Cell Lymphoma in the Rituximab Era
Blood 2020 Jul 30;[EPub Ahead of Print], S Bobillo, E Joffe, JA Lavery, D Sermer, P Ghione, A Noy, PC Caron, AM Hamilton, PA Hamlin, SM Horwitz, A Kumar, MJ Matasar, AJ Moskowitz, C Owens, ML Palomba, C Batlevi, DJ Straus, G von Keudell, AD Zelenetz, J Yahalom, A Dogan, VE Seshan, A Younes

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading